General characteristics, economic burden, causative drugs and medical errors associated with medical damage litigation involving severe cutaneous adverse drug reactions in China.

Journal of Clinical Pharmacy and Therapeutics
Zao-Qian ZhengJin-Yu Luo

Abstract

To investigate the general characteristics, economic burden, causative drugs and medical errors associated with litigation involving severe cutaneous adverse drug reactions (SCADRs) in China, with the aims of improving rational medication use and reducing the extent of damage from SCADRs. This study analysed 150 lawsuit judgements involving SCADRs from 2005 to 2019, collected from China Judgments Online. In total, 50% of lawsuits stemmed from SCADRs occurring in general hospitals. The average time elapsed from the date of occurrence of the SCADRs to the end of litigation procedures was 1055 days. Of the patients involved, 51% were female and more than two thirds (69%) were under 60 years old. The most common outcome of SCADRs was death (39%), followed by disabilities (30%). The average responsibility of the medical provider was 48 ± 29%. The average amount of compensation was $43 424. Of the cases studied, 51% of SCADRs were Stevens-Johnson syndrome or toxic epidermal necrolysis, which together accounted for 75% of cases with known clinical subtype. The overall average economic burden of SCADRs was $99 178, of which indirect costs made up the largest proportion (more than 60%). The most common causative drug groups were antimic...Continue Reading

References

Jan 10, 1991·The New England Journal of Medicine·P C CoyteM J Trebilcock
Dec 14, 1995·The New England Journal of Medicine·J C RoujeauF Locati
Jun 1, 1993·International Journal of Dermatology·V LeenutaphongP Sunthonpalin
Nov 10, 1994·The New England Journal of Medicine·J C Roujeau, R S Stern
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Apr 13, 2001·JAMA : the Journal of the American Medical Association·K NakajimaK Tatara
Mar 2, 2002·Clinical Medicine : Journal of the Royal College of Physicians of London·Stephen M Breathnach
May 12, 2006·The New England Journal of Medicine·David M StuddertTroyen A Brennan
Jan 1, 2008·Indian Journal of Dermatology·Surajit Nayak, Basanti Acharjya
Oct 5, 2010·The Journal of Allergy and Clinical Immunology·Antonino RomanoPhilippe Jean Bousquet
Jun 28, 2011·International Journal of Dermatology·Inès ZaraaAmel Ben Osman
Oct 22, 2011·Expert Review of Clinical Immunology·Maja Mockenhaupt
Apr 27, 2013·Indian Journal of Dermatology, Venereology and Leprology·Tejas K PatelChandrabhanu Tripathi
Jul 30, 2014·International Journal of Dermatology·Peiqi Su, Chen Wee Derrick Aw
Aug 26, 2014·BMJ Open·Yishi JiangUNKNOWN HESVIC team authorship
Sep 4, 2014·Anais Brasileiros De Dermatologia·Luciana Rosa GrandoRenato Marchiori Bakos
Sep 17, 2014·Journal of Psychiatric Practice·Sheldon H Preskorn
Jan 17, 2015·Indian Dermatology Online Journal·Tejas K PatelDc Sharma
Jun 13, 2017·Bulletin of the World Health Organization·Zhan WangChee-Ruey Hsieh
Dec 1, 2017·Anais Brasileiros De Dermatologia·Qiancheng DengJinhua Huang
Dec 5, 2018·Journal of Forensic and Legal Medicine·Leyin ZhouGuohong Li
Jul 28, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Mojtaba VaismoradiHege Sletvold
Oct 15, 2019·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Giulia LiccioliElio M Novembre
Oct 28, 2019·International Journal of Clinical Pharmacy·Lama Al Damen, Iman Basheti
Nov 8, 2019·Current Pharmaceutical Design·Hakan GuvenirEmine Dibek Misirlioglu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.